News
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jun 20, 2019General corporate updates and plans for second half of 2019
Creative Medical Technology Holdings, Inc. (OTCQB: CELZ), a leading commercial stage biotechnology company focused on Urology, Orthopedics and Neurology using stem cell treatments, today announced...
-
May 6, 2019
Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today coverage of its patented CaverStem ® technology for treatment of erectile dysfunction using the patient's own...
-
Apr 30, 2019
(OTCQB-CELZ) Creative Medical Technology Holdings, Inc. announced today an update of its activities: As we are releasing updates on a regular basis, we will only cover new activities. The absence...
-
Mar 28, 2019
(OTCQB-CELZ) Creative Medical Technology Holdings, Inc. announced today an update of its activities: CaverStem™ domestic activities: As previously reported, we are continuing marketing to...
-
Feb 12, 2019
(OTCQB-CELZ) Creative Medical Technology Holdings, Inc. announced today an update of it's activities: This update addresses the goals set for Q1 2019 with regard to the ongoing commercialization...
-
Dec 27, 2018
(OTCQB-CELZ) Creative Medical Technology Holdings, Inc. announced today an update of its activities: As we end 2018 we look forward to continuing to reach multiple milestones in 2019. CaverStemTM...
-
Nov 14, 2018
(OTCQB-CELZ) Creative Medical Technology Holdings, Inc. announced today an update of its activities: The company has timely filed its 10Q on 11-14-18, contained in the 10Q is predominantly...
-
Nov 6, 2018
Creative Medical Technology Holdings, Inc. (OTCQB ticker symbol CELZ) announced today that as a continuation of the Brand Building of its CaverStemTM technology, it has awarded a contract to...
-
Oct 17, 2018
(OTCQB-CELZ) Creative Medical Technology Holdings, Inc. announced today an update of its activities: Creative Medical Health, Inc. shall convert $100,000.00 of deferred management compensation to...
-
Sep 24, 2018
(OTCQB-CELZ) Creative Medical Technology Holdings, Inc. announced today an update of its progress: Debt: We have entered into an agreement with three institutional investors in order to wrap up...
-
Sep 4, 2018
(OTCQB-CELZ) Creative Medical Technology Holdings, Inc. announced today an update of its activities. CaverStemTM: Domestic recruitment, vetting and training of physicians on the CaverStemTM...
-
Aug 14, 2018
(OTCQB-CELZ) Creative Medical Technology Holdings, Inc. announced today an update of its corporate activities. Debt: Since our last 8k on debt reduction an additional $268,858.00 has been...
-
Jul 19, 2018
Creative Medical Technology Holdings Inc. (OTCQB ticker symbol CELZ) announced today that its subsidiary Caverstem International LLC has signed an exclusive contract with Promo Med Russia for the...
-
Jul 6, 2018Company Sees Possible Access to AmnioStemTM for Cancer Patients under "Right to Try" Law
Creative Medical Technology Holdings, Inc. (OTCQB: CELZ) announced today initiation of a program aimed at treating cancer associated wasting, through the in-licensing of patent application...
-
Jun 19, 2018Subsidiary to concentrate on International Erectile Dysfunction Market
Creative Medical Technology Holdings (OTCQB:CELZ) announced today the formation of CaverStem International LLC, a majority owned subsidiary focused on commercializing stem cell therapy for...
-
May 30, 2018
Creative Medical Technology Holdings, Inc. (OTCQB ticker symbol CELZ) announced today that Gary Mells has been hired to lead the CaverStem™ marketing and sales division of the company. "Mr....
-
May 23, 2018Dr. Alexander Gershman Discusses Positive Outcomes in Initial Erectile Dysfunction Patients Who Received Their Own Bone Marrow Stem Cells
Creative Medical Technology Holdings (OTCQB:CELZ) announced today completion of its 3 day exhibition at the American Urology Association (AUA) meeting. The Company's presentations where delivered...
-
May 8, 2018
Creative Medical Technology Holdings announced today filing of patent application number 62663912 covering the use of its AmnioStemTM stem cells as a means of reducing/reversing natural aging....
-
May 8, 2018
Creative Medical Technology Holdings Inc. (OTCQB ticker symbol CELZ) announced today that Dr. Alexander Gershman will attend the AUA conference on May 19 th and 20th with Creative Medical...
-
Apr 30, 2018
Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today that debt to two lenders in the amount of $163,000.00 has been retired. As previously announced Creative Medical Technology...
-
Apr 23, 2018
Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today that additional debt in the amount of $332,000.00 has been extinguished. As previously announced Creative Medical Technology...
-
Apr 12, 2018The Company's Stem Cell Therapies to be Main Subject at Dr. James Veltmeyer's Congressional Health Care Symposium
Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today it will be giving the Keynote Address at the Veltmeyer Health Care Innovations Symposium April 12 th, 2018 in San Diego, CA....
-
Apr 12, 2018
Creative Medical Technology Holdings, Inc. (OTCQB: CELZ) announced today that debt to affiliate company Creative Medical Health, Inc. in the amount of $136,003.00 is being converted to restricted...
-
Apr 4, 2018New Data Opens Door to Addressing Multi-Billion Dollar Autoimmune Market
Creative Medical Technology Holdings (OTCQB: CELZ) announced today new data demonstrating superior immune modulatory ability of its AmnioStem™ stem cell product when compared head-to-head with...
-
Mar 27, 2018
Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today that debt from four early round lenders totaling $255,000.00 of principal has been extinguished. As with many small...